Morning Overview on MSN
An mRNA vaccine paired with Keytruda cut melanoma recurrence by nearly 50% over five years in a landmark NYU-led trial
Patients with high-risk melanoma who received a personalized mRNA cancer vaccine alongside pembrolizumab after surgery saw ...
A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in ...
MarketBeat on MSN
Arcturus Therapeutics highlights mRNA pipeline, CF data and vaccine expansion at Jefferies
Arcturus Therapeutics (NASDAQ:ARCT) President and CEO Joseph Payne outlined the company's messenger RNA programs, vaccine ...
When used alongside Merck’s Keytruda, Moderna’s personalized cancer vaccine halved the risk of death or disease recurrence in ...
J&J's Rybrevant and cancer vaccines are showing benefit During the American Society of Clinical Oncology (ASCO) meeting 2026, ...
An experimental vaccine from Moderna shows promise in keeping deadly skin cancer from returning for years, according to new ...
WASHINGTON (AP) — So-called mRNA vaccines saved millions of lives during the COVID-19 pandemic — and now scientists are using that Nobel Prize-winning technology to try to develop vaccines and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results